Showing results (561-570 of 612) with videos related to

Sort By:
Pageof 62
Multiple Sclerosis Journal - Experimental, Translational and Clinical|October 8, 2019
Tuberculosis screening in multiple sclerosis: effect of disease-modifying therapies and lymphopenia on the prevalence of indeterminate TB screening results in the clinical settingLaura E Baldassari, Jenny Feng, Gabrielle Macaron, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|March 1, 2021
Remote administration of the symbol digit modalities test to individuals with multiple sclerosis is reliable: A short reportTehila Eilam-Stock, Michael T Shaw, Kathleen Sherman, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|February 23, 2023
Axonal and myelin changes and their inter-relationship in the optic radiations in people with multiple sclerosisEva A Krijnen, Chanon Ngamsombat, Ilena C George, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|February 28, 2025
Treatment persistence and clinical outcomes in patients starting B cell depleting therapies within the Swiss MS CohortGiulio Disanto, Sabine Schaedelin, Johanna Oechtering, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|February 11, 2025
Validation of the Swedish Multiple Sclerosis registry for pediatric-onset multiple sclerosisFredrik Sandesjö, Peter Alping, Katharina Fink, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|March 20, 2025
Evaluation of patient-perceived fatigue in multiple sclerosis utilizing the Finnish MS registryPäivi Hämäläinen, Matias Viitala, Merja Soilu-Hänninen, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|October 16, 2024
Exploring the relationship between neurologists and older persons with multiple sclerosis through the lens of social support theoryMina Stanikić, Felix Gille, Jonas Schlomberg, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 2, 2024
Early clinical effect of cladribine in patients with highly active multiple sclerosis in MexicoSergio Sauri-Suarez, Sandra Quiñones, Manuel De la Maza-Flores, et al.
Pageof 62